e-learning
resources
Munich 2006
Monday 04.09.2006
Asthma - miscellaneous issues
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Disturbances of STAT6 signaling in steroid-free asthma
V. N. Mineev, L. N. Sorokina (Saint Petersburg, Russian Federation)
Source:
Annual Congress 2006 - Asthma - miscellaneous issues
Session:
Asthma - miscellaneous issues
Session type:
Electronic Poster Session
Number:
2900
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. N. Mineev, L. N. Sorokina (Saint Petersburg, Russian Federation). Disturbances of STAT6 signaling in steroid-free asthma. Eur Respir J 2006; 28: Suppl. 50, 2900
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Analysis of cytokine signaling through the STAT6 activation in patients with atopic steroid-free asthma
Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy
Year: 2007
Notch pathway signaling in asthma
Source: Annual Congress 2006 - Markers of paediatric airway disease
Year: 2006
Analysis of cytokine signaling pathway JAK-STAT through their activation in patients with asthma
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
Nlrc5 is involved in allergic airway inflammation and negatively regulates inflammatory signaling pathway via TLR2/NF-?B.
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
Interleukin-17 cytokine signalling in patients with asthma
Source: Eur Respir J 2014; 44: 1319-1331
Year: 2014
Activation of TGFβ/Smad signalling pathway in induced sputum of asthmatic children
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002
Inhibition of VEGF blocks the activation of TGF-β
1
through a PI3K/Akt signaling pathway in allergic airway disease of mice
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007
Impaired MAP kinase-dependent modulation of transcription factor T-bet in T-lymphocytes from asthmatics - role of dexamethasone
Source: Eur Respir J 2005; 26: Suppl. 49, 233s
Year: 2005
Dysregulation of ZFP36L1 and ZFP36L2 in severe asthma alters epithelial integrity and dampens genome-wide glucocorticoid responses
Source: Virtual Congress 2021 – Early manifestations of chronic respiratory disease: zooming in at the epithelial barrier
Year: 2021
Role of IL-33 signaling in pollutant-induced allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
CREB signaling and chromatin remodeling during corticosteroid and theophylline therapy of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 355s
Year: 2007
Role of dexamethasone and MAPkinases ERK and p38MAPK on T-bet expression and IFNγ release in peripheral blood lymphocytes from atopic asthmatics
Source: Eur Respir J 2006; 28: Suppl. 50, 229s
Year: 2006
Improvement of allergic asthma symptoms by targeting STAT6 with siRNA
Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment
Year: 2008
Suppressor of cytokine signalling 1 (SOCS1) and asthma exacerbations
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018
Activation of IL-32 pathway in COPD
Source: Annual Congress 2008 - Cell biology of asthma and COPD
Year: 2008
Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma
Source: Eur Respir J 2010; 35: 750-756
Year: 2010
PP103 – Dysregulation of ZFP36L1 and ZFP36L2 in asthma alters epithelial integrity and genome-wide glucocorticoid responses
Source: ERS Lung Science Conference 2021
Year: 2021
Low-level laser therapy effect on the bronchial hyperresponsiveness and the chronic allergy airway inflammation is driven to RhoA signaling and STAT-6
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
New aspects of the action of IL-4 on the activity of the transcription factor STAT6 in allergic and non-allergic asthma
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept